OVID THERAPEUTICS INC. IR

press release · 2023

OV329, a GABA Aminotransferase (GABA-AT) Inhibitor, Suppresses Hippocampal Pyroxysmal Discharges in a Human Translational Mesial Temporal Lobe Epilepsy (MTLE) Mouse Model